Recommendation of Final Dividend for the financial year ended March 31, 2025

Corporate Actions View source PDF Explain this filing

ABBOTINDIA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.0%Reaction day

₹30230.00

prior close

₹31000.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.9%+0.1% vs market

Pharmaceuticals peers, median of 150sector+0.2%+0.8% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Midcap 150 and 0.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.0

10m

+0.2

15m

-0.3

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.0+0.9+0.1+0.2+0.8

Next day

+1.6+1.0+0.5+1.1+0.4

+2.2-0.6+2.7+0.1+2.0

+3.9+0.2+3.6+1.0+2.9

+2.8-0.1+2.9+1.2+1.6

+1.8+0.4+1.4+0.7+1.1

+0.6+1.2-0.6+1.4-0.7

15d

+3.5+4.4-0.8+0.6+2.9

+4.8+3.9+0.9+2.1+2.7

+12.9+5.8+7.0+3.8+9.1

+7.8+2.3+5.5-1.0+8.8

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Abbott India's Board of Directors, at its meeting held on May 15, 2025, has recommended a final dividend of Rs. 475 per equity share (on a face value of Rs. 10 each) for the financial year ended March 31, 2025. The dividend is subject to shareholder approval at the upcoming 81st Annual General Meeting scheduled for August 13, 2025. If approved, the dividend will be paid on or after August 18, 2025. This represents a substantial payout, with the dividend being 47.5 times the face value per share.

Likely market impact

This is a significant cash return for shareholders. Shareholders holding Abbott India shares as of the record date (yet to be announced) would receive a sizable dividend. The recommendation signals strong profitability and healthy cash generation by the company, which is generally viewed positively by investors.